Influenza Vaccination in Patients Living With HIV in the Northern Region
NCT04402684 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 124
Last updated 2021-01-26
Summary
Anyone living with the Human Immunodeficiency Virus (HIV) has an indication for annual influenza vaccination. (Vaccination schedule and vaccination recommendations 2019). Influenza is a viral infection that has a significant impact on the health care system. However, vaccination coverage in France is still insufficient with regard to the objectives set at 75% by the WHO and the European Commission. For the 2019-2020 seasonal influenza vaccination campaign, flu vaccination by volunteer pharmacists has become possible throughout the country. Studies that have estimated vaccination coverage among HIV-positive populations are rare and show very low rates.
Conditions
Sponsors & Collaborators
-
Tourcoing Hospital
lead OTHER
Principal Investigators
-
Macha TETART, MD · CH TOURCOING
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-04-10
- Primary Completion
- 2020-09-30
- Completion
- 2020-12-30
Countries
- France
Study Locations
More Related Trials
-
Safety of and Immunogenicity to an H1N1 Influenza Vaccine in HIV-infected Adults
NCT01155037 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy of Influenza Vaccine in HIV Infected Adults
NCT00757900 ·Status: COMPLETED ·Phase: PHASE4
-
Immunogenicity of COVID-19 Vaccination in PLWH
NCT04894448 ·Status: UNKNOWN
-
Immune Activation Markers in HIV-infected Patients Switching to Long Acting Dual Therapy
NCT05433987 ·Status: COMPLETED
-
Influenza Vaccine in HIV Infection: Immune Response and Effect on Viral Load
NCT00025922 ·Status: COMPLETED
-
Immunogenicity, Safety, and Tolerability of MF59-Adjuvanted Versus Non-Adjuvanted Influenza Vaccines in Patients With HIV-1 Infection
NCT01032408 ·Status: COMPLETED ·Phase: PHASE3
-
Conventional Vaccine and Intradermal Vaccine Among HIV-infected Young Subjects
NCT02398097 ·Status: COMPLETED ·Phase: PHASE4
-
Clinical Trial to Evaluate the Immunogenicity and Safety of an Adjuvanted A(H1N1)v Influenza Vaccine and a Non-adjuvanted A(H1N1)v Influenza Vaccine in HIV-infected Patients (ANRS 151 Hifluvac)
NCT01008813 ·Status: COMPLETED ·Phase: PHASE2
-
H1N1 Influenza Vaccine Immunogenicity in HIV-1 Infected Patients
NCT01111162 ·Status: COMPLETED ·Phase: PHASE4
-
Shedding, Immunogenicity and Safety of Quadrivalent Live Intranasal Influenza Vaccine (QLAIV) in HIV-infected Children and Young Adults
NCT02474901 ·Status: COMPLETED ·Phase: PHASE2
-
Exploring Novel Mechanisms of Vaccine Failure LAIV Pilot Study
NCT02266992 ·Status: COMPLETED ·Phase: PHASE2
-
Influenza Vaccination at a Reduced Dose Using Mesotherapy in HIV/AIDS Patients at the Hadassah AIDS Center, Jerusalem
NCT00758212 ·Status: UNKNOWN ·Phase: NA
-
Vaccines in a Time of Dual Pandemic: COVID-19 Vaccine in People With HIV
NCT06731127 ·Status: COMPLETED
-
To Evaluate Effectiveness and Safety of Containing Raltegravir in Naive HIV NON B or B Infected Patients
NCT01162538 ·Status: UNKNOWN
-
Influenza Vaccination of HIV Infected Pregnant Women: Safety and Immunogenicity
NCT01306682 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Serological Responses to Adjuvanted Versus Non-adjuvanted Influenza Vaccines Among People With HIV: a Randomized Clinical Trial
NCT07126652 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
A Study of Raltegravir in a Diverse Cohort of HIV-Infected Patients (0518-055)
NCT00764946 ·Status: COMPLETED ·Phase: PHASE3
-
Immunogenicity and Safety of Recombinant Zoster Vaccine in People Living With HIV
NCT05898464 ·Status: COMPLETED ·Phase: PHASE4
-
Study to Compare the Immunogenicity and Safety of Two HIV Preventive Vaccinations in Healthy Volunteers
NCT00490074 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Safety and Immune Response of COVID-19 Vaccination in Patients With HIV Infection
NCT05043129 ·Status: UNKNOWN
-
Vaccination Response in ImmunoCompromised Host. Immune Response After Vaccination Against Pandemic A/H1N1 Influenza
NCT01066169 ·Status: COMPLETED
-
Immunogenicity and Safety of Trivalent Influenza Vaccine in Non-pregnant HIV-infected Women
NCT01812980 ·Status: COMPLETED ·Phase: PHASE4
-
H1N1 Vaccine at Two Dose Levels in HIV Positive Adults
NCT00992433 ·Status: COMPLETED ·Phase: PHASE2
-
Immunogenicity of Novel H1N1 Vaccination Among HIV-Infected Compared to HIV-Uninfected Persons
NCT00996970 ·Status: COMPLETED
-
Perturbing of HIV Reservoir With Immune Stimulation
NCT02707692 ·Status: COMPLETED ·Phase: NA